Titian Software, HighRes Biosolutions Collaborate
News May 13, 2016
HighRes Biosolutions and Titian Software have worked closely to enable linkage of Titian’s market leading Mosaic™ sample management software with HighRes’ Cellario™ automation system control software. This close collaboration has resulted in the integration of Mosaic’s powerful inventory control and sample tracking with the potent laboratory automation capabilities of Cellario.
This collaborative effort closes a gap in compound management information flow by facilitating direct communication between Titian’s widely used Mosaic sample management system and Cellario’s dynamic scheduling software. The net result is to provide users with a seamless and much more efficient workflow. Titian’s new Cellario Fulfillment Module (CFM) interfaces with HighRes’ Cellario Order Broker™ (COB) to simplify the entire process of sample preparation, including lab ware placement, consumables loading, and liquid handling.
Ira Hoffman, Managing Director of HighRes Biosolutions declared: “We are excited to work with Titian on this development. We believe that this software integration that has resulted in the development of the Cellario Order Broker™ will allow our customers to focus on their business, and not the details of the integration between these two informatics platforms. This should result in significant time savings in translating the planned work into actual production with results – physical and logical – being reported and tracked in real time. The resulting Cellario Order Broker’s upfront order validation will ensure accurate, efficient, error-free processing from Mosaic orders.”
Edmund Wilson, CEO and Founder of Titian Software added: “By working together with HighRes, we have allowed their range of automation systems to be leveraged within Mosaic sample preparation workflows. We know that this collaboration will provide significant time savings and improve operational efficiency for our shared Compound Management customers. This capability gives the Compound Management user total visibility and traceability of their samples from initial compound request through to assay plate creation.”
An artificial intelligence (AI) approach based on deep learning convolutional neural network (CNN) could identify nuanced mammographic imaging features specific for recalled but benign (false-positive) mammograms and distinguish such mammograms from those identified as malignant or negative.
2nd International Conference on Computational Biology and Bioinformatics
May 17 - May 18, 2019